Propionic Acidemia Clinical Trial
Official title:
A Phase 2 Open-label, Dose Escalation Study of HST5040 in Subjects With Propionic or Methylmalonic Acidemia Followed by a Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study and an Open-label, Long-term Extension Study
This is an interventional study to assess the safety, PK, and efficacy of HST5040 in 12 subjects - 6 with Methylmalonic Acidemia (MMA) and 6 with Propionic Acidemia (PA). The study consists of 3 parts: - Part A: Open-label, within-subject, dose escalation study in PA and MMA subjects ≥ 2 years old to identify a safe and pharmacologically active (optimal) dose of HST5040 for use in Part B. Subjects will continue in a Part A open-label extension until all subjects complete Part A and the optimal dose of HST5040 is identified for use in Part B. - Part B: 6-month, randomized, double-blind, placebo-controlled, 2-period crossover in the same subjects from Part A to evaluate safety and efficacy of the optimal dose of HST5040 in addition to standard of care (SoC). - Part C: open-label long-term extension study in PA and MMA subjects ≥ 2 years old (N = approximately 12, 6 each) to evaluate the long-term safety and efficacy of the optimal dose of HST5040. This study will determine whether HST5040 can improve levels of disease-associated toxins that accumulate in patients with PA and MMA.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05842837 -
A Non-Interventional Post-Authorization Study of Carbaglu for the Treatment of Hyperammonemia Due to MMA and PA
|
||
Recruiting |
NCT05687474 -
Baby Detect : Genomic Newborn Screening
|
||
Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
Recruiting |
NCT05130437 -
A Long-Term Extension Study to Evaluate the Safety and Clinical Activity of mRNA-3927
|
Phase 1/Phase 2 | |
Recruiting |
NCT02890342 -
Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia
|
||
Completed |
NCT02426775 -
Carglumic Acid in Methylmalonic Acidemia and Propionic Acidemia
|
Phase 3 | |
Terminated |
NCT04836494 -
A First in Human, Dose Escalation Study to Evaluate the Safety and Tolerability of BBP-671 in Healthy Volunteers and Patients With Propionic Acidemia or Methylmalonic Acidemia
|
Phase 1 | |
Completed |
NCT03484767 -
"The MaP Study": Mapping the Patient Journey in MMA and PA
|
||
Recruiting |
NCT05040178 -
An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics
|
||
Recruiting |
NCT05769621 -
A Retrospective Study to Characterize Participants With Propionic Acidemia
|
||
Completed |
NCT00645879 -
Anaplerotic Therapy in Propionic Acidemia
|
Phase 1 | |
Recruiting |
NCT04176523 -
Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach
|
||
Withdrawn |
NCT01341379 -
Increasing Ureagenesis in Inborn Errors of Metabolism With N-Carbamylglutamate
|
Phase 2 | |
Terminated |
NCT05438485 -
Natural History Study of Patients With Methylmalonic Acidemia and Propionic Acidemia
|
||
Completed |
NCT03159026 -
Review of Charts From Amish/Mennonite Variant PA Patients
|
||
Recruiting |
NCT04159103 -
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
|
Phase 1/Phase 2 |